Welcome!

iPhone Authors: An Bui, Scott McKain, RealWire News Distribution, Kevin Benedict

News Feed Item

Houston and New York Dermatologist Discusses Allergan's JUVEDERM VOLUMA XC and Volume Loss in the Cheeks

Dr. Paul M. Houston Explains How JUVEDERM VOLUMA XC Can Provide Patients With Immediate Volume Enhancement of the Cheek and Mid-Face Region

HOUSTON, TX -- (Marketwired) -- 06/05/14 -- Dr. Paul M. Friedman, a board-certified dermatologist in Houston and New York, has added JUVÉDERM VOLUMA™ XC to his line of non-surgical injectable procedures. As the first and only U.S. Food and Drug Administration-approved filler for correcting age-related volume loss, JUVÉDERM VOLUMA™ XC specifically restores fullness to the cheeks and midfacial area for patients age 21 and over. Dr. Friedman says he is pleased to offer patients the injectable gel treatment as another aesthetic option to help achieve a more youthful, refreshed appearance.

In a recent blog post titled, "Key Benefits of JUVÉDERM VOLUMA™ XC," Dr. Friedman says that one of the most appealing characteristics of JUVÉDERM VOLUMA™ XC is its longevity. Although the product is composed of hyaluronic acid (HA) (similar to other fillers), it's made of a thicker injectable substance, which causes it to degrade more slowly. In many cases and with optimal treatment, JUVÉDERM VOLUMA™ XC can last up to 24 months, says Dr. Friedman. He notes that, for patients seeking to enhance their facial contours and achieve an overall softer, more supple appearance, JUVÉDERM VOLUMA™ XC can serve as an effective solution.

The product is uniquely formulated to restore volume to all three areas of the cheek, which include the apex, apple, and hollow. Since JUVÉDERM VOLUMA™ XC is designed for a deep level of injection, the filler also contains .3 percent Lidocaine, a local anesthetic, to help minimize discomfort during the procedure.

Ultimately, Dr. Friedman says that in addition to its long-lasting effects, JUVÉDERM VOLUMA™ XC makes an appealing option because of a number of distinct benefits, including its ability to achieve:

  • Results that are typically noticeable immediately after treatment
  • Smooth results that often look and feel natural
  • Enhanced fullness to cheeks and cheekbone region
  • Diminished lines and wrinkles in the midface

The new injectable is available at the Dermatology Laser & Surgery Center, located in Houston and New York City. Dr. Friedman says that he is looking forward to offering JUVÉDERM VOLUMA™ in addition to his practice's comprehensive selection of other injectables, such BOTOX® Cosmetic, BELOTERO BALANCE®, and Restylane®, in order to provide patients with a better opportunity to find the right solution for their aesthetic needs.

About Paul M. Friedman, MD
Dr. Paul M. Friedman is certified by the American Board of Dermatology and is the Director of Dermatology & Laser Surgery Center of Houston, Texas and New York City, New York. Upon earning his medical degree, Dr. Friedman went on to complete his fellowship in dermatologic laser surgery, Mohs micrographic surgery, and cutaneous oncology at the Laser & Skin Surgery Center of New York. Dr. Friedman is the co-author of "Beautiful Skin Revealed: The Ultimate Guide to Better Skin," co-editor of the textbook "Laser & Light Source Treatments For The Skin," and serves as a Clinical Assistant Professor at the University of Texas Medical School, Department of Dermatology, and as a Clinical Assistant Professor of Dermatology at Weill Cornell Medical College, The Methodist Hospital. Dr. Friedman is available for interview upon request.

To learn more about Dr. Friedman and the Dermatology & Laser Surgery Center, please visit dermlasersurgery.com and facebook.com/paulmfriedmanmd.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2610456

Dermatology & Laser Surgery Center
Houston Office
Memorial Hermann Medical Plaza
6400 Fannin Street #2720
Houston, TX 77030
(713) 900-3900

New York Office
317 E. 34th St.
New York City, NY 10016
(917) 745-5029

Rosemont Media
Email Contact
(858) 200-0044
www.rosemontmedia.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.